Pushing the Bounds of Typology: Jewish Carnality and the Eucharist in Jörg Ratgeb\u27s Herrenberg Altarpiece

Jörg Ratgeb’s Herrenberg Altarpiece (1518-1519) depicts well-established examples of Christian iconography, but appears to reconfigure and intensify traditional subjects and subject matter through the inclusion of overt anti-Judaic references. In this paper, my focus is the strong anti-Judaic subject matter of the Herrenberg Altarpiece and the local context in which, and for which, it was created. The anti-Jewish representations are investigated by exploring Christian perceptions of biblical and contemporary Jews, identifying social tensions in Swabia that may have influenced how Jews were depicted, and recognizing the ways in which the trope of Jewish wantonness may have served a politico-religious agenda in the region. Given the Eucharistic overtones of the altarpiece, I also argue that anxieties in Christian practice concerning the presence of Christ’s true body and blood in the consecrated Eucharist could be, and often were, exacerbated by Christian perceptions of Jews and “judaizing.

A Behavioral Approach to Understanding the Git Experience

The Investigating and Archiving the Scholarly Git Experience (IASGE) project is multi-track study focused on understanding the uses of Git by students, faculty, and staff working in academic research institutions as well as the ways source code repositories and their associated contextual ephemera can be better preserved. This research, in turn, has implications regarding how to support Git in the scholarly process, how version control systems contribute to reproducibility, and how Library and Information Science (LIS) professionals can support Git through instruction and sustainability efforts. In this paper, we focus on a subset of our larger project and take a deep look at what code hosting platforms offer researchers in terms of productivity and collaboration. For this portion, a survey, focus groups, and user experience interviews were conducted to gain an understanding of how and why scholarly researchers use Version Control Systems (VCS) as well as some of the pain points in learning and using VCS for daily work

ARCHIVING THE SCHOLARLY GIT EXPERIENCE - iPRES 2019 Amsterdam

Our poster will reflect our recent efforts to understand the workflows and policies needed for the long-term preservation of code, annotations, and other scholarly ephemera from Git hosting platforms. We undertook an environmental scan of the existing processes and tools for capturing and actively archiving Git data and their associated, supplemental materials. We will present the results of this broad environmental scan, covering a wide variety of approaches, organizations, and workflows that could possibly be used to create a baseline on which to build and expand archival tools. Our efforts are geared toward acquiring, archiving, and providing permanent access to source code, and the materials around it, and argue that the whole should be considered part of the scholarly record

GeoJSON Data Curation Primer

This work was created as part of the Data Curation Network “Specialized Data Curation” Workshop #2 held at Johns Hopkins University April 17-18, 2019.GeoJSON is a geospatial data interchange format for encoding vector geographical data structures, such as point, line, and polygon geometries, as well as their non-spatial attributes. The purpose of this primer is to guide a data curator through the curation process for GeoJSON files.Institute of Museum and Library Services RE-85-18-0040-18

Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell

Patients with post-haemopoietic stem cell transplant or chimeric antigen receptor T -cell (CAR-T) therapy face a significant risk of morbidity and mortality from coronavirus disease 2019 because of their immunosuppressed state. As case numbers in Australia and New Zealand continue to rise, guidance on management in this high-risk population is needed. Whilst we have learned much from international colleagues who faced high infection rates early in the pandemic, guidance relevant to local health system structures, medication availability and emerging therapies is essential to equip physicians to manage our patients optimally

Nine Best Practices for Research Software Registries and Repositories: A Concise Guide

Scientific software registries and repositories serve various roles in their respective disciplines. These resources improve software discoverability and research transparency, provide information for software citations, and foster preservation of computational methods that might otherwise be lost over time, thereby supporting research reproducibility and replicability. However, developing these resources takes effort, and few guidelines are available to help prospective creators of registries and repositories. To address this need, we present a set of nine best practices that can help managers define the scope, practices, and rules that govern individual registries and repositories. These best practices were distilled from the experiences of the creators of existing resources, convened by a Task Force of the FORCE11 Software Citation Implementation Working Group during the years 2019-2020. We believe that putting in place specific policies such as those presented here will help scientific software registries and repositories better serve their users and their disciplines

Nine Best Practices for Research Software Registries and Repositories: A Concise Guide

18 pagesScientific software registries and repositories serve various roles in their respective disciplines. These resources improve software discoverability and research transparency, provide information for software citations, and foster preservation of computational methods that might otherwise be lost over time, thereby supporting research reproducibility and replicability. However, developing these resources takes effort, and few guidelines are available to help prospective creators of registries and repositories. To address this need, we present a set of nine best practices that can help managers define the scope, practices, and rules that govern individual registries and repositories. These best practices were distilled from the experiences of the creators of existing resources, convened by a Task Force of the FORCE11 Software Citation Implementation Working Group during the years 2019-2020. We believe that putting in place specific policies such as those presented here will help scientific software registries and repositories better serve their users and their disciplines

The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe (vol 75, pg 2027, 2022)

10.1093/cid/ciac730CLINICAL INFECTIOUS DISEASES75111532-153

Risk of COVID-19 after natural infection or vaccinationResearch in context

Summary: Background: While vaccines have established utility against COVID-19, phase 3 efficacy studies have generally not comprehensively evaluated protection provided by previous infection or hybrid immunity (previous infection plus vaccination). Individual patient data from US government-supported harmonized vaccine trials provide an unprecedented sample population to address this issue. We characterized the protective efficacy of previous SARS-CoV-2 infection and hybrid immunity against COVID-19 early in the pandemic over three-to six-month follow-up and compared with vaccine-associated protection. Methods: In this post-hoc cross-protocol analysis of the Moderna, AstraZeneca, Janssen, and Novavax COVID-19 vaccine clinical trials, we allocated participants into four groups based on previous-infection status at enrolment and treatment: no previous infection/placebo; previous infection/placebo; no previous infection/vaccine; and previous infection/vaccine. The main outcome was RT-PCR-confirmed COVID-19 >7–15 days (per original protocols) after final study injection. We calculated crude and adjusted efficacy measures. Findings: Previous infection/placebo participants had a 92% decreased risk of future COVID-19 compared to no previous infection/placebo participants (overall hazard ratio [HR] ratio: 0.08; 95% CI: 0.05–0.13). Among single-dose Janssen participants, hybrid immunity conferred greater protection than vaccine alone (HR: 0.03; 95% CI: 0.01–0.10). Too few infections were observed to draw statistical inferences comparing hybrid immunity to vaccine alone for other trials. Vaccination, previous infection, and hybrid immunity all provided near-complete protection against severe disease. Interpretation: Previous infection, any hybrid immunity, and two-dose vaccination all provided substantial protection against symptomatic and severe COVID-19 through the early Delta period. Thus, as a surrogate for natural infection, vaccination remains the safest approach to protection. Funding: National Institutes of Health